Atorus / GSK Package Release

May 24, 2021

In August 2020, Atorus and GSK entered a unique relationship. As two separate organizations both committed to the advancement of...


Highlighting SAS Chunks in RMarkdown

March 8, 2021

SAS is a major player in the clinical trial world, and as R enthusiasts here at Atorus, finding ways that...


Building a ggplot2 Theme

February 3, 2021

Several graphs are created within the clinical trial space for a single submission. While there is a lot of domain...


Obstacles and Opportunities With Open-Source Vlog

January 7, 2021

Chief Innovation Officer Michael Stackhouse addresses closed-source-mentality obstacles, the opportunities the open-source community creates, and how the drug development industry...


Benefits of R Language Vlog

December 16, 2020

Is there a benefit to using R language in drug development in particular? Chief Innovation Officer Michael Stackhouse describes how...


Benefits of Open Source Vlog

December 10, 2020

Atorus Research Chief Innovation Officer Michael Stackhouse explains the benefits of using open source in the drug development industry.


Tplyr Version 0.2.2 Released

December 2, 2020

It’s been about 2 months since we initially released Tplyr out to CRAN, and in the time since then we’ve...


Open Source and Collaboration

November 20, 2020

The rapid development of open source technology is consistently amazing. The landscape has changed so dramatically in just the last...


Multilingual Markdown with R and Python Using Reticulate

October 21, 2020

Atorus Research presented their Multilingual Markdown workshop at R/Pharma last week. In this workshop, they presented the interoperability between Python...


Why Open Source?

September 23, 2020

Before venturing further into methodology and the results of the replication, it is worthwhile to explore the question of why...